Find Academic Supervisors

Vibha BhargavaView profile

Research Professor

• Family Resource Management
• Consumer Economics
• Food Insecurity and Health
• +3 more

Dr. Vibha Bhargava is a Research Professor in the College of Family and Consumer Sciences at the University of Georgia , housed within the Department of Financial Planning, Housing and Consumer Economics . She also holds an appointment in Nutritional Sciences and serves as an Evaluation Specialist, bridging research and policy impact. Education Ph.D. in Family Resource Management, Ohio State University (2007) M.S. in Consumer and Family Economics, University of Missouri-Columbia (2002) M.S. in Home Science, Maharaja Sayajirao University of Baroda, India (1997) B.S. in Home Science, Govind Ballabh Pant University of Agriculture and Technology, India (1995) Research Interests Dr. Bhargava’s scholarship centers on how social, economic, and public policy factors shape the health and health-care decisions of individuals and families across the lifespan. Her work disentangles the pathways linking food insecurity to physical and mental health outcomes , evaluates the protective role of public assistance programs (e.g., SNAP, Medicare), and examines the influence of health literacy on older adults’ health-care utilization. Publication Themes & Trends Spanning 2012–2019, her 12 selected articles reveal a consistent focus on vulnerable populations —low-income households, older adults, and adolescents—within the intersecting domains of nutrition, health economics, and consumer finance . Studies repeatedly leverage large survey datasets to quantify how food insecurity exacerbates chronic disease, increases out-of-pocket medical spending, and undermines medication adherence. Parallel threads explore financial resilience after bankruptcy and the integration of complementary medicine into conventional care. Awards & Honors No specific scientific awards or fellowships were mentioned in the provided text. Advising & Grants Dr. Bhargava mentors a robust cohort of graduate researchers , including Ph.D. and M.S. students whose names appear as co-authors across her publications. While explicit grant numbers are absent, the breadth and continuity of funded projects (e.g., SNAP evaluation, produce prescription pilots) indicate sustained external funding from agencies such as USDA, NIH, or private foundations. Labs & Teams She conducts interdisciplinary research that straddles the Institute on Human Development and Disability and collaborates closely with faculty in Nutritional Sciences and Human Development and Family Science , forming synergistic teams to address complex socio-health challenges.

• Pediatric Ophthalmology
• Strabismus
• Telemedicine in Ophthalmology
• +3 more

Sudha Nallasamy, MD, serves as Associate Professor of Clinical Ophthalmology at Children's Hospital Los Angeles (CHLA) with academic affiliation to the University of Southern California. Specializing in pediatric ophthalmology and strabismus, she maintains active clinical and research roles within CHLA's ophthalmology department. Education: MD, University of Pennsylvania School of Medicine (2005), recipient of Howard Hughes Medical Institute Medical Student Fellowship Ophthalmology Residency, Children's Hospital of Philadelphia (2009) Pediatric Ophthalmology & Strabismus Fellowship, Children's Hospital Boston Dr. Nallasamy's research focuses on innovative solutions for pediatric eye care, with particular emphasis on telemedicine applications, health equity in amblyopia treatment, and myopia progression management. Her work bridges clinical practice with technological advancements to improve accessibility and outcomes for children with visual disorders. Current investigations include AI-generated patient education tools and disparities in treatment compliance across sociodemographic groups. Analysis of her 15 most recent publications (2022-2025) reveals a dominant focus on telemedicine validation studies (60% of articles), particularly asynchronous and real-time video consultations for conditions like blepharoptosis and retinopathy of prematurity. Complementary research explores AI applications in surgical education, myopia control interventions, and health disparities - demonstrating both methodological diversity and clinical relevance across pediatric ophthalmology subspecialties. Scientific Awards: Pasadena Magazine Top Doctors (2014) AAPOS Best of Show Tour selections (2010, 2008) Children's Hospital Boston Farley Award (2009) Heed Ophthalmic Foundation Fellowship (2009) Howard Hughes Medical Institute Fellowship (2003) Multiple undergraduate honors including Phi Beta Kappa and Case Western Reserve University Presidential Scholarship Dr. Nallasamy actively contributes to academic discourse through peer-reviewed publications and professional society engagements, with research supported by institutional resources at CHLA/USC. Her leadership in developing telemedicine protocols and educational tools demonstrates commitment to advancing pediatric ophthalmology practice standards. While specific grant details aren't provided, her consistent publication record in top journals indicates sustained research productivity within CHLA's academic framework. Though not explicitly detailed in source materials, her clinical focus suggests active participation in CHLA's pediatric ophthalmology division, potentially contributing to multidisciplinary teams managing complex cases involving genetic disorders and systemic diseases with ocular manifestations.

• Palliative Care
• Medical Education
• Pain Management
• +3 more

Vandana Nagpal, MD is an Associate Professor in the Department of Medicine at UMass Chan Medical School, specializing in Palliative Care within the T.H. Chan School of Medicine. Her clinical and academic work bridges patient care, medical education, and systems improvement in palliative medicine. MBBS in Medicine and Surgery from Dayanand Medical College, Ludhiana, Punjab, India Dr. Nagpal's research centers on optimizing palliative care delivery through educational innovation and clinical systems redesign. She investigates serious illness communication, pain management protocols, and interventions to combat compassion fatigue among healthcare providers. Her work emphasizes practical, implementable solutions using electronic health records, simulation training, and longitudinal wellness programs that directly impact clinical practice and resident education. Analysis of her 2020-2025 publications reveals consistent focus on palliative care integration across specialties, particularly in neurology and internal medicine. Key thematic clusters include resident well-being initiatives, goals-of-care documentation systems, transdermal opioid safety, and humanizing interventions during crisis periods like the COVID-19 pandemic. Her research demonstrates strong translational impact, moving from simulation training to bedside application and electronic record implementation. Dr. Nagpal's contributions have earned significant recognition: 2025 Sarah Stone Excellence in Education Award, UMass Chan Medical School 2023 Outstanding Clinical Educator Award and Specialty Advisor of the Year Award 2021 Leonard Tow Humanism in Medicine Award and AAHPM Fellowship 2017 Sarah Stone Excellence in Teaching Award 2013 ACP Fellowship As Specialty Advisor of the Year (2023), she mentors medical students in UMass Chan Learning Communities while leading palliative care education for residents. Her funded projects include the longitudinal resident wellness initiative and catastrophic stroke palliative care access study, demonstrating successful grant acquisition for implementation science. Current collaborations with Reidy, Osgood, and Silver focus on neurology communication training and EMR-based care improvements. Dr. Nagpal co-leads the Palliative Care Division's educational initiatives at UMass Chan Medical School, working closely with interdisciplinary teams including social workers, chaplains, and neurology specialists. Her research group actively develops simulation curricula and EMR interventions while analyzing real-world implementation data to refine best practices in serious illness care.

Fawzy A. ElbarbryView profile

Professor

• Drug Metabolism
• Pharmacokinetics
• Herbal Remedies
• +10 more

Fawzy A. Elbarbry is a Professor at Pacific University in the College of Health Professions Department of Pharmacy. He holds a PhD in Pharmacy (Drug Metabolism and Pharmacokinetics) from the University of Saskatchewan (2006), an MS in Analytical Chemistry from the University of Tanta (2002), and a BS in Pharmaceutical Sciences (1993). He is Board Certified in Pharmacotherapy (BCPS, 2018) and completed a Postdoctoral Fellowship in the Department of Medicine at the University of Saskatchewan (2006). PhD , Pharmacy (Drug Metabolism and Pharmacokinetics), University of Saskatchewan, Canada (2006) MS , Analytical Chemistry, University of Tanta, Egypt (2002) BCPS , American Pharmacists Association (2018) FPGEC , National Association of Boards of Pharmacy (2010) His research focuses on drug metabolism , particularly the impact of herbal remedies on drug-metabolizing enzymes and arachidonic acid metabolism for hypertension treatment . Recent work identified sulforaphane from broccoli as a potential antihypertensive agent through inhibition of arachidonic acid metabolism, with implications for herb-drug interactions . Dr. Elbarbry has received significant funding, including an NIH grant of $365,966 for a three-year project on alternative hypertension treatments. His publications span topics like pharmacokinetics in amputees , serotonin toxicity from antibiotics , and natural product translation to clinical practice . NIH Grant ($365,966, 2021) – Alternative Treatments for Hypertension Board Certified Pharmacotherapy Specialist (BCPS) – American Pharmacists Association (2018) His work integrates pharmacokinetics , natural product research , and clinical pharmacology to address challenges in drug interactions and cardiovascular disease management.

• International Refugee Law
• Regional Refugee Law
• Climate Change Displacement
• +7 more

Dr. Tamara Wood is a Senior Lecturer in Law at the University of Tasmania's Faculty of Law and concurrently serves as a Senior Research Fellow at the Kaldor Centre for International Refugee Law, UNSW Sydney since October 2023. Her expertise spans international refugee law, regional refugee frameworks (particularly in Africa), climate change displacement, and complementary protection pathways. She advises organizations such as UNHCR, IOM, and the World Bank, and leads initiatives like the Climate Mobility Africa Research Network (CMARN). Education: PhD (UNSW Sydney), LLB (Hons 1) & BA (University of Melbourne) Teaching: International Refugee Law, Australian Public Law, Constitutional Law Her research focuses on refugee protection in crises, disaster displacement, and free movement agreements. She has published in journals like the International and Comparative Law Quarterly and chairs the International Journal of Refugee Law Case Law Editorial Team. Dr. Wood's advisory roles include the Platform on Disaster Displacement and the Institute for Security Studies Africa. She supervises doctoral research on African refugee frameworks and climate migration solutions.

Ute KrengelView profile

Professor

• Structural Biology
• X-ray Crystallography
• Protein-Carbohydrate Interactions
• +5 more

Professor Ute Krengel is a distinguished structural biologist at the University of Oslo, where she has held a full professorship since 2006. She leads research in the Section for Chemical Life Sciences, focusing on proteins of medical interest, particularly enzymes and protein-carbohydrate interactions. Her work combines X-ray crystallography with complementary structural biology techniques to gain atomic-level insights into biological mechanisms with potential therapeutic applications. Professor Krengel received her PhD from the University of Heidelberg in 1991 with research on the structure and molecular mechanism of p21 ras. Her academic journey includes research positions in Toronto (1991-1993), Groningen (1994-1997), and Gothenburg (1997-2004) before settling at the University of Oslo. In 2018, she served as a visiting professor at ETH Zurich. Her research program centers on understanding the molecular basis of disease mechanisms, particularly in infectious diseases and cancer, with emphasis on receptor interactions and enzymatic processes. Krengel's laboratory investigates metabolic enzymes, lectins, adhesins, toxins, and anti-cancer antibodies , recognizing that protein-carbohydrate interactions are fundamental to numerous biological processes including metabolism, cellular signaling, differentiation, cell-cell interactions, and immune responses. Her work has significant implications for developing new treatments against human diseases. Professor Krengel's recent publication record demonstrates consistent productivity and evolving research directions. Her work spans structural characterization of bacterial toxins, anti-tumor antibodies, and enzyme mechanisms, with increasing focus on applications in immunotherapy and infectious disease treatment. The interdisciplinary nature of her research is evident in collaborations across biochemistry, molecular modeling, bioinformatics, NMR spectroscopy, cryo-EM, and mass spectrometry. Professor Krengel currently serves in significant leadership roles including coordinator of the Norwegian Block Allocation Groups for Synchrotron Research and as the Norwegian representative of the International Glycoconjugate Organization, highlighting her standing in the international scientific community. Her research is conducted through active collaboration with diverse research groups, ensuring structural characterization is integrated with protein engineering, carbohydrate binding studies, molecular simulations, and drug design. She leads projects on lectins, bacterial toxins, anti-tumor antibodies, and chorismate mutase, contributing to the Bio3 - Chemical Life Sciences research group and participating in the Glyconor Consortium and PX-Oslo structural biology initiatives.

Chris Koon Ho WONGView profile

Associate Professor

• Fungal pathogenesis
• Transcription regulation
• Medical mycology
• +3 more

Chris Koon Ho WONG is Associate Professor in the Faculty of Health Sciences at the University of Macau. He leads a research group investigating fungal pathogenesis and transcriptional regulation, with the dual aims of developing new antifungal therapies and understanding conserved eukaryotic gene-control mechanisms. He teaches genetics & epigenetics to undergraduates and mentors a vibrant team of six PhD candidates and two research assistants. Education PhD, Department of Genetics, University of Melbourne, Australia (2007) BSc (First Class Honours), Department of Genetics, University of Melbourne, Australia (2002) BSc, Faculty of Science, University of Melbourne, Australia (2001) Diploma, Biotechnology, Ngee Ann Polytechnic, Singapore (1999) Research Interests Prof Wong’s laboratory pursues two complementary themes: 1. Fungal Pathogenesis – dissecting how medically important fungi such as Candida spp. and Aspergillus fumigatus cause life-threatening infections in immunocompromised patients and leveraging this knowledge to discover novel antifungal targets. 2. Transcriptional Regulation – elucidating the conserved molecular machinery that governs gene expression in eukaryotes, using fungi as tractable models to inform human biology and disease. Publication Trends Since 2016 his work has appeared regularly in Nature Microbiology , Nature Communications , Cell Research and Nucleic Acids Research . The papers demonstrate a progressive shift from mechanistic studies of fungal transcription toward translational applications including antifungal drug discovery, chromatin-level regulation of virulence, and the development of bioinformatic tools for fungal genomics. Scientific Awards Marine Biological Laboratory Scholarship, USA (2013) Croucher Postdoctoral Fellowship, Hong Kong (2009–2010) International Postgraduate Research Scholarship, Australian Government (2003–2006) Melbourne International Research Scholarships (2003–2006) Howitt Natural History Scholarship (2001–2003) Department of Genetics Postgraduate & Honours Scholarships (2002–2003) Dean’s Honours List – B.Sc.(Hons), University of Melbourne (2002) Advising & Research Team Prof Wong currently supervises six PhD students—Zhengqiang Miao, Qing Lan, Weng In Chong, Pin Wu, Shen Li, Lin Bi and Xiaofeng Liu—and employs two research assistants, Yiwen Huang and Zhiqiang Dong. His laboratory is located in rooms E12-2075/2077 at the University of Macau.

Anthony RosenzweigView profile

Professor

• Cardiovascular Research
• Heart Failure
• Exercise Physiology
• +5 more

Dr. Anthony Rosenzweig, Professor of Internal Medicine - Cardiology at the University of Michigan Medical School, is a leading figure in cardiovascular research with a focus on heart failure, exercise physiology, and molecular cardiology. He previously held the Paul Dudley White Professorship of Medicine at Harvard Medical School (2015-2022) and served as Chief of Cardiology and Director of Cardiovascular Research at Massachusetts General Hospital. Harvard College (Biochemistry & Molecular Biology) Harvard Medical School (MD) Massachusetts General Hospital (Residency & Fellowship) University of Pennsylvania (Predoctoral Fellowship) Harvard Medical School (Postdoctoral Training) His research spans multiple groundbreaking areas including: Exercise-induced cardiac lymphatic remodeling for aging heart inflammation miRNA-based therapies for chemotherapy-induced cardiotoxicity Traditional Chinese Medicine applications in heart failure treatment (QLQX clinical trials) Stem cell-derived cardiomyocyte purification techniques Neural pathways linking stress to cardiovascular benefits Placental senescence mechanisms in peripartum cardiomyopathy Scientific contributions include leadership in the QUEST trial showing Qiliqiangxin's efficacy for HFrEF and pioneering work on exercise-regulated noncoding RNAs reversing vascular aging. He currently directs the Stanley and Judith Frankel Institute for Heart and Brain Health at University of Michigan. Paul Dudley White Professor of Medicine (2015-2022) Inaugural Director, Frankel Institute for Heart and Brain Health Leadership roles at MGH, Beth Israel Deaconess, and Harvard Stem Cell Institute Active in clinical translation, his work bridges molecular cardiology with regenerative medicine and metabolic research, while maintaining significant advisory roles in major cardiovascular organizations.

Mark R. SpallerView profile

Associate Professor

• Protein biochemistry
• Peptide science
• PDZ domain interactions
• +5 more

Mark R. Spaller is an Associate Professor of Medical Education at the Geisel School of Medicine at Dartmouth College, with adjunct appointments in Biological Sciences and Chemistry. He is affiliated with the Norris Cotton Cancer Center and serves as Associate Professor of Pharmacology & Toxicology. Dr. Spaller received his B.S. and Ph.D. from the University of Texas at Austin. His research focuses on protein-ligand and protein-protein interactions of biological and medicinal significance, particularly those regulating oncogenic and neuronal signal transduction pathways. His laboratory employs an interdisciplinary approach combining organic and peptide synthesis, protein biochemistry, molecular biology, and biophysics. Current research areas include: PDZ Domains & Neurobiology PDZ Domains & Cancer Protein-Ligand Interactions Design & Synthesis of Anticancer Chemical Libraries His publication record demonstrates consistent productivity across multiple disciplines, with recent work focusing on pancreatic cancer mechanisms, neuronal signaling pathways, and the development of peptide-based therapeutics targeting specific protein domains. Dr. Spaller's research has particular relevance to cancer therapeutics and neurological disorders. Dr. Spaller actively mentors both graduate and undergraduate students in his laboratory, providing them with multidisciplinary training that spans chemical synthesis, biochemistry, and molecular biology techniques. His laboratory culture emphasizes collaboration both within the group and with external research teams specializing in complementary methodologies.

• Genetic Epidemiology
• Molecular Epidemiology
• Breast Cancer
• +5 more

Jonine Lisa Bernstein is a Researcher at the Department of Epidemiology & Biostatistics at Memorial Sloan Kettering Cancer Center (MSK). She serves as Co-Leader of the Population Sciences Research Program and leads the WECARE Study (Women’s Environmental, Cancer, and Radiation Epidemiology), focusing on genetic susceptibility, radiation therapy effects, and environmental factors in contralateral breast cancer. Her research spans genetic and molecular epidemiology of breast cancer and gliomas, with emphasis on broad fields including Genetic Epidemiology , Cancer Risk Prediction , and Radiation-Associated Cancers . Key Research Areas: Genetic susceptibility to contralateral breast cancer Development/validation of imaging biomarkers (e.g., mammographic density, MRI background parenchymal enhancement) Gene-environment interactions in cancer progression Non-cancer outcomes post-breast cancer treatment Molecular pathoepidemiology of gliomas Her recent publications analyze radiation-induced breast cancer risks, DNA repair gene variants, and AI-driven GWAS. She collaborates with institutions like Stanford and MD Anderson on glioma studies and serves on advisory boards for the U.S. EPA and Radiation Effects Research Foundation. Scientific awards include leadership roles in the American College of Epidemiology and American Epidemiological Society.

• Conservation Genomics
• Food Authentication
• Environmental DNA
• +2 more

Valeria Taurisano is a Research Fellow and PhD candidate in the Department of Agricultural and Food Sciences at the University of Bologna. Her research applies genetic and genomic tools to livestock species (pigs, cattle, rabbits) and wild organisms (sea cucumbers, honeybees) for conservation management, food authentication, and environmental monitoring. Key innovations include environmental DNA analysis from honey for entomological authentication and population monitoring, genomic characterization of local livestock breeds for conservation, and development of molecular methods for food traceability. She employs diverse molecular techniques including DNA/RNA extraction, PCR-RFLP, Sanger and NGS sequencing, and bioinformatic analysis. Publications demonstrate consistent advancement in conservation genomics applications, particularly non-invasive monitoring using environmental DNA from food matrices. Recent work develops reference databases for honeybee subspecies identification, NUMT characterization in pig genomes, and genomic selection for disease resistance in rabbits. Active in multiple projects characterizing Italian autochthonous breeds including Mora Romagnola pigs and Reggiana cattle. Supervised by Professor Luca Fontanesi, her doctoral research investigates genetic factors influencing meat quality traits in Italian heavy pigs.

David VauzourView profile

Associate Professor

• Neurodegenerative Disorders
• Phytochemicals
• Neuroinflammation
• +5 more

David Vauzour is an Associate Professor in Molecular Nutrition at the University of East Anglia’s Norwich Medical School. He is a member of the Norwich Institute for Healthy Aging, Metabolic Health, and Nutrition and Preventive Medicine groups. His research focuses on dietary strategies to delay neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s) and cardiovascular diseases via mechanisms involving polyphenols, neuroinflammation, and APOE4 genotype interactions. Education: PhD in Chemical and Biological Sciences from University Montpellier 1, France; MSc and BSc in Biological/Molecular Sciences from University Bordeaux 2, France. Professional memberships include the Groupe Polyphenols and Biochemical Society. Key research areas include phytochemicals’ effects on brain aging, molecular mechanisms of neuroprotection, and translational studies linking diet to personalized medicine. He leads projects funded by BBSRC, MRC, and industry partners (e.g., Naturex, Microphyt SA) targeting interventions for menopause-related cognitive decline and gut-brain axis modulation. Recent work emphasizes gut microbiota’s role in cognitive health, with studies on saffron extracts, Mediterranean diets, and prebiotic/probiotic solutions. His lab investigates APOE4 genotype impacts on disease risk and dietary responsiveness, particularly in aging populations.

Xiaoqiu HuangView profile

Professor

• Bioinformatics
• Computational Biology
• Sequence Alignment
• +4 more

Xiaoqiu Huang is a Professor and Associate Chair for Faculty Professional Development in the Department of Computer Science at Iowa State University. His research focuses on bioinformatics and computational biology, with contributions to sequence alignment algorithms, genome assembly, gene finding, and phylogenetic reconstruction. He developed widely used tools like CAP3 and PCAP for DNA sequence assembly, and his work addresses evolutionary mechanisms in asexual fungal pathogens. Education: Ph.D. in Computer Science from Pennsylvania State University (1990). Affiliations: Associate Editor for BMC Bioinformatics; core contributor to interdepartmental bioinformatics programs. Research Interests: Huang's work bridges algorithm development and biological applications, including: - Sequence Alignment: Linear-space algorithms for efficient genomic comparisons. - Genome Assembly: CAP3 (short reads) and PCAP (large genomes), used in landmark projects like the chimpanzee and chicken genome assemblies. - Horizontal Theory: Proposes horizontal transfer as a key driver of genetic diversity in asexual fungi, involving supernumerary chromosomes and het genes. Publications: Over 70 peer-reviewed articles, including foundational work on alignment algorithms (e.g., Huang-Miller algorithm) and recent studies on fungal pathogen evolution. Recent trends emphasize genomic diversity, structural variants, and complementary evolutionary theories. Labs/Teams: Leads development of bioinformatics software (CAP3, PCAP, AAT) used globally. Collaborates on projects analyzing fungal pathogens, yeast adaptation, and soybean resistance mechanisms.

Paul NeilsenView profile

Professor

• Cancer Biology
• Cell Biology
• Molecular Genetics
• +3 more

Paul Neilsen is the Head of College for Clinical Sciences at CQUniversity’s School of Health, Medical and Applied Sciences. He holds a PhD in Cancer Cell Biology from the University of Adelaide (2008) and has established the Sarcoma Research Group. His research focuses on cancer genetics, molecular pathogenesis of sarcomas, and drug discovery from natural products. He has published 33 articles (h-index 16, 916 citations), secured over $1M in grants (NHMRC, Cancer Australia), and led research centers in Malaysia. His administrative roles include Director of Graduate Studies at Swinburne University Sarawak Campus and Associate Director of Health Sciences. Research Interests: Cancer biology, oncology, p53 pathway modulation, plant-derived therapeutics, and epigenetic drug development. He is accredited to supervise students in Biochemistry, Cell Biology, and Oncology. Publications highlight contributions to anticancer drug screening, natural product isolation, and mechanisms of chemotherapy resistance. His work intersects plant chemistry with clinical oncology, particularly in designing novel therapies for sarcomas and lung cancer. Awards include an NHMRC Career Development Fellowship (2014) and grants supporting his sarcoma research. Current teaching roles include coordinating units in clinical biochemistry, medical science research, and pharmacology at both undergraduate and postgraduate levels. Labs/Teams: Founder of the Sarcoma Research Group; collaborates on projects involving natural product libraries, epigenetic drug screening, and molecular oncology at CQUniversity.

• Endocrine
• Neuroscience
• Oxidative Stress
• +4 more

Mehmet AYDIN, M.D. is a Professor at Uskudar University's School of Medicine, currently serving as Vice Dean. His research focuses on endocrine systems, neuroscience, oxidative stress mechanisms, complementary medicine, and physiological processes. He holds a Prof. Dr. title and has supervised at least one master's thesis on occupational therapy interventions involving plant cultivation for university students. Administrative roles include membership in graduation commissions and faculty web development committees. His work spans experimental surgery outcomes, environmental toxin effects, and pharmacological interventions in various disease models. Teaching responsibilities include courses in medical curricula from 2023 onwards. Education: Doctorate in Medicine (specific details pending) Key Research Areas: Gut hormones, diabetes epigenetics, neuroprotective compounds, endocrine disruptors, and surgical material testing Awards: None explicitly listed Grants/Projects: No details provided Thesis Supervision: Menekşe Yüksel (2025) on cognitive effects of plant cultivation interventions Labs/Teams: Not specified in provided data Publications highlight experimental studies in gastroenterology, neuroendocrinology, and toxicology, with a focus on translational research linking basic science to clinical applications.